Making cold malignant pleural effusions hot: driving novel immunotherapies-Reference-Cited by-同舟云学术

Making cold malignant pleural effusions hot: driving novel immunotherapies

Published:2019-01-22 Issue:4 Volume:8 Page:e1554969
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Murthy Pranav¹^ORCID,Ekeke Chigozirim N.²,Russell Kira L.¹,Butler Samuel C.²^ORCID,Wang Yue¹³,Luketich James D.²,Soloff Adam C.²^ORCID,Dhupar Rajeev²⁴,Lotze Michael T.¹²³⁵^ORCID

Affiliation:

1. Department of Surgery, University of Pittsburgh, Pittsburgh, PA, USA

2. Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA, USA

3. Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA

4. Department of Surgery, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA, USA

5. Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA

Funder

National Institutes of Health

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2018.1554969

Reference264 articles.

1. An update in the management of malignant pleural effusion

2. Malignant pleural effusion: from bench to bedside

3. Important prognostic factors for survival in patients with malignant pleural effusion

4. Hunting for a pleural fluid test for mesothelioma: is soluble mesothelin the answer?

5. Malignant pleural fluid from mesothelioma has potent biological activities

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Palliative Care for Patients With Breast Cancer in a Palliative Care Unit of a Japanese Hospital;Cureus;2024-08-26

2. Enzyme-Dynamic Extracellular Vesicles for Metalloimmunotherapy of Malignant Pleural Effusions;ACS Nano;2024-08-07

3. CCL11/CCR3-dependent eosinophilia alleviates malignant pleural effusions and improves prognosis;npj Precision Oncology;2024-06-29

4. Immunotherapeutic hydrogel for co-delivery of STAT3 siRNA liposomes and lidocaine hydrochloride for postoperative comprehensive management of NSCLC in a single application;Asian Journal of Pharmaceutical Sciences;2024-06

5. Exploratory pilot study to characterize the immune landscapes of malignant pleural effusions and their corresponding primary tumors from patients with breast carcinoma and lung adenocarcinoma;Journal of the American Society of Cytopathology;2024-05